SAFRYCYN WOUND CREAM DRESSING WITH HYALURONIC ACID-

Safrycyn WOUND CREAM DRESSING WITH HYALURONIC ACID by

Drug Labeling and Warnings

Safrycyn WOUND CREAM DRESSING WITH HYALURONIC ACID by is a Other medication manufactured, distributed, or labeled by Lifsa Drugs LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

SPL UNCLASSIFIED SECTION

DESCRIPTION: Safrycyn is a soothing wound Cream that is formulated for the dressing and management of superficial wounds, minor abrasions, pressure ulcers stage II - IV, 1st and 2nd degree burns, including sunburns, and radiation dermatitis. When applied properly to a wound hyaluronic acid adheres to tissue to prevent damage while supplying moisture to the cells. Proven therapeutic moisturizers, lipids and glycerin and relieves dryness

INDICATIONS FOR USE

Under the supervision of a healthcare professional, Safrycyn Cream is indicated to manage and relieve the burning, itching and pain experienced with various types of dermatoses, including atopic dermatitis, allergic contact dermatitis and radiation dermatitis. Safrycyn Cream also helps to relieve dry, waxy skin by maintaining a moist wound and skin environment, which is beneficial to the healing process.

DESCRIPTION

Safrycyn Cream is a non-sterile, off-white, low odor, fragrance free, topical product. The Safrycyn Cream forms a physical barrier that helps to maintain a moist wound and skin environment. Safrycyn Cream is a prescription medical device.

CONTRAINDICATIONS

Safrycyn Cream is contraindicated in persons with a known hypersensitivity to any of the components of the formulation.

WARNINGS

External use only. Do not use this product if you are allergic to any of the ingredients. Avoid contact with eyes. KEEP OUT OF REACH OF CHILDREN.

FOR TOPICAL USE ONLY

NOT FOR OPTHALMIC USE

PRECAUTIONS AND OBSERVATIONS

Safrycyn Cream does not contain a sunscreen and should not be used prior to extended exposure to the sun.
If clinical signs of infection are present, appropriate treatment should be initiated; use of Safrycyn Cream may be continued during the anti-infective therapy.

INSTRUCTIONS FOR USE

Wound should be cleaned and disinfected. Apply Safrycyn cream to the affected area. Change the dressing based on the extent of the wound fluid, if wound exudates from primary and secondary dressings, change the dressing more frequently.

INGREDIENTS

Sodium Hyaluronate (0.2% w/w), Emulsifying Wax, Glycerol, Isopropyl palmitate, Potassium Phosphate Monobasic, Methyl Paraben, Propyl paraben and purified water

HOW SUPPLIED

Safrycyn Cream is available in 42.5 grams Tube.

Rx Only CAUTION: Federal law restricts this device to sale by or on the order of a licensed healthcare practitioner.

Storage: Store below 85° F(30°C). Do not freeze. Keep tube tightly closed after use. Protect from freezing [see USP Controlled Room Temperature].

SPL UNCLASSIFIED SECTION

Distributed by:
Lifsa Drugs LLC
New Brunswick, NJ 08901

NC: TS/DRUGS/30/2005

Made in India

Packaging

INGREDIENTS AND APPEARANCE

SAFRYCYN WOUND CREAM DRESSING WITH HYALURONIC ACID 
dressing, wound, drug

Product Information
Product Type	PRESCRIPTION MEDICAL DEVICE	Item Code (Source)	NHRIC:72336-819

Inactive Ingredients
Ingredient Name	Strength
HYALURONATE SODIUM (UNII: YSE9PPT4TH)
MICROCRYSTALLINE WAX (UNII: XOF597Q3KY)
GLYCERIN (UNII: PDC6A3C0OX)
ISOPROPYL PALMITATE (UNII: 8CRQ2TH63M)
MONOBASIC POTASSIUM PHOSPHATE (UNII: 4J9FJ0HL51)
METHYLPARABEN (UNII: A2I8C7HI9T)
PROPYLPARABEN (UNII: Z8IX2SC1OH)
WATER (UNII: 059QF0KO0R)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NHRIC:72336-819-28	1 in 1 BOX
1		42.5 g in 1 TUBE; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
premarket notification	K172747	08/06/2025

Labeler - Lifsa Drugs LLC (081205160)